GlassScriptPhysician profile
Norris M Allen
NPI 1972634822
$1,978.13
in general payments reported to CMS, 2019-2025
29 companies · $496 in 2025
The $496 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $65.02 · 2021: $83.08 · 2022: $497 · 2023: $303 · 2024: $408 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,122 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,122.46 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $373.06 | 2023-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $194.32 | 2022-2025 | Myosure Tissue Removal Device, Novasure, Omni Hysteroscope |
| Exeltis, USA INC. | $190.09 | 2022-2025 | Slynd |
| Abbvie INC. | $186.24 | 2019-2024 | Lo Loestrin Fe, Orilissa |
| Mayne Pharma Commercial LLC | $157.30 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $109.91 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $88.50 | 2020-2022 | |
| Therapeuticsmd, INC. | $85.32 | 2022 | |
| Pfizer INC. | $58.22 | 2023-2024 | |
| Organon LLC | $57.50 | 2021-2024 | |
| Myovant Sciences INC. | $48.80 | 2022 | |
| Minerva Surgical, INC | $44.88 | 2021 | |
| Daiichi Sankyo INC. | $42.41 | 2020-2025 | Injectafer |
| Shield Therapeutics INC | $39.32 | 2024-2025 | |
| Coopersurgical, INC. | $28.41 | 2022-2024 | Paragard T 380a |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $24.35 | 2025 | Zurzuvae |
| Millicent US INC | $24.08 | 2025 | Femlyv |
| Mylan Pharmaceuticals INC. | $23.37 | 2022 | |
| Ascend Therapeutics US, LLC | $23.29 | 2024 | |
| Collegium Pharmaceutical, INC. | $21.87 | 2025 | Jornay Pm |
| Pacira Pharmaceuticals Incorporated | $20.24 | 2019 | |
| Abbott Laboratories | $19.59 | 2025 | Jot Dx |
| Gynesonics, INC. | $18.40 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Amgen INC. | $18.18 | 2019 | |
| Agile Therapeutics, INC. | $17.00 | 2022 | |
| Medtronic, INC. | $16.83 | 2023 | Truclear |
| Karl Storz Endoscopy-America | $16.51 | 2021 | |
| Merck Sharp & Dohme LLC | $15.28 | 2019 | |
| Avion Pharmaceuticals | $14.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norris Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.